Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00454194 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: pemetrexed disodium
DRUG: sorafenib tosylate

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]